期刊文献+

病毒介导的P53低表达HepG2细胞株的建立

Establishment of retrovirus-mediated P53 low expression HepG2 cell line
下载PDF
导出
摘要 目的构建干扰P53的逆转录病毒载体,建立稳定低表达P53的HepG2细胞株。方法合成干扰P53基因的寡核苷酸序列插入pMSCV-hyg-U6质粒,转化受体菌DH5α,经酶切测序鉴定后瞬时转染HepG2细胞,通过半定量RT-PCR方法检测P53 mRNA表达水平评估干扰效果;选择干扰效果最好的重组质粒转染PT67细胞进行病毒包装,获得逆转录病毒颗粒感染HepG2细胞,通过Hygromycin筛选获得多个细胞克隆,Western blot检测P53蛋白的表达情况;选择P53表达水平最低的细胞克隆。通过5-氟尿嘧啶(5-FU)诱导凋亡实验,检测P53低表达的HepG2细胞p53通路介导的细胞凋亡情况。结果经酶切和测序验证成功构建重组病毒载体;瞬时转染HepG2细胞后P53 mRNA表达下调;病毒颗粒感染HepG2细胞后P53的mRNA、蛋白表达下调;用5-FU处理后P53低表达HepG2细胞凋亡水平明显低于对照。结论成功构建了干扰P53的逆转录病毒载体,建立了P53低表达HepG2细胞株,明显阻断了P53通路依赖的细胞凋亡。 In this study, we aimed to establish HepG2 cell line with stably low expression of P53 by using virus-mediated RNA interference technology. P53 siRNA retrovirus expression vectors were constructed with pMSCV-hyg-U6, and then transfected into PT67 package cells. Virus suspension was collected to infect HepG2 cell lines. RT-PCR was used to detect the expression level of P53 mRNA and Western blot was used to analyze the protein level of P53. HepG2 cell line with stably low expression of P53 was treated with 5-FU, and flow cytometry were used to detected cell apoptosis. We found that the expression level of P53 mRNA was down-regulated after HepG2 cells were transient transfected with the recombinant plasmid. The expression of P53 protein was down-regulated after HepG2 cells were infected with the recombinant retrovirus. Apoptosis level of HepG2 cell line with stably low expression of P53 was significantly lower than the control. In our study, the RNAi retroviral vector targeting to P53 was successfully constructed and HepG2 cell line with stably low expression of P53 were established, in which the P53 pathway-dependent apoptosis was significantly blocked. Thus this study would set a basis for evaluating the role of P53 pathway in the pathologic processes of infection and tumor.
出处 《免疫学杂志》 CAS CSCD 北大核心 2012年第6期493-496,共4页 Immunological Journal
基金 国家自然科学基金(30800983 BWS11J041 81170396) 重庆市自然科学基金(2008BB5113) 重庆市卫生局医学科研项目(2011-2-411)
关键词 逆转录病毒 P53 HEPG2 RNA干扰 细胞凋亡 Retrovirus P53 HepG2 siRNA Apoptosis
  • 相关文献

参考文献9

  • 1Anwesha D, David PL, Chandra SV. Modulating the p53pathway[J]. Semin Cancer Biol, 2010, 20(1): 3-9.
  • 2Krimpenfort P, Song JY, Proost N, et aL Deleted in colorectal carcinoma suppresses metastasis in p53-deficient mammary tumours[J]. Nature, 2012, 482(7386):538-541.
  • 3Beothe riP, Nagy A, Farkas L, et al. P53 Mutation and LOH at Chromosome 9 in Urothelial Carcinoma [J].Anticancer Res, 2012, 32(2):523-527.
  • 4Takaoka AS, Hayakawa H, Yanai D, et al. Integration of interferonalphafoeta signalling to p53 responses in tumour suppressionandantiviraldefence [J]. Nature, 2003,424(6948): 516-523.
  • 5MunozFontela C, Macip S, MartinezSobrido L, et al. Transcri-ptional role of p53 in interferon mediated antiviral immunity[J]. J Exp Med, 2008, 205(8): 1929 - 1938.
  • 6Su WC, Liu WL, Cheng CW, et al. Ribavirin enhances interferon signaling via stimulation of mTOR and p53 activities [J]. FEBS Lett, 2009, 583(17):2793-2798.
  • 7孙宝昌,靳宝峰,梁冰,李爱玲,钭慧芬,陈栋,周涛.载体介导的小干扰RNA诱导p53基因的沉默[J].生物技术通讯,2008,19(3):340-343. 被引量:2
  • 8毛丽伟,王卫东,廖国清,王红梅,陈正堂.放射诱导正反馈基因环路调控Wt-p53表达对肺腺癌移植瘤的抑制作用[J].免疫学杂志,2010,26(6):473-476. 被引量:4
  • 9Muooz-Fontela C, Gonz á lez D, MarcosVillar L, et al. Acetylation is indispensable for p53 antiviral activity [J]. CeU Cycle, 2011,10(21):3701-3705.

二级参考文献30

  • 1黄晓春,刘晋祎,周燕虹,敖琳,杨录军,曹佳.昆明山海棠总生物碱对人结肠癌HCT116细胞裸鼠皮下移植瘤生长的影响[J].免疫学杂志,2009,25(5):547-549. 被引量:4
  • 2Weichselbaum RR, Kufe DW, Advani SJ. Molecular targeting of gene therapy and radio therapy [J]. Acta Oncol, 2001, 40(6):735-738.
  • 3Hu Y, Ouyang W, Wu F. Enhanced radiosensitivity of SW480 cells via TRAIL up-regulation mediated by Egr-1 promoter[J]. Oncol Rep, 2009, 22(4):765-771.
  • 4Scott SD, Marples B, Hendry JH. A radiation-controlled molecular switch for use in gene therapy of cancer [J]. Gene Ther, 2000, 7(13):1121-1125.
  • 5Kobayashi T, Chen L, Aibara K. Modeling genetic switches with positive feedback circuits[J]. J Theor Biol, 2003, 221(3): 379-399.
  • 6Karig D, Weiss R. Signal-amplifying genetic circuit enables in vivo observation of weak promoter activation in the Rhl quorum sensing system [J]. Biotechnol Bioeng, 2005, 89(1): 46-50.
  • 7Mezhir JJ, Smith KD, Posner MC. Ionizing radiation: a genetic switch for cancer therapy [J]. Cancer Gene Ther, 2006, 13(1):1-6.
  • 8Greco O, Powell TM, Marples B. Gene therapy vectors containing CArG elements from the Egrl gene are activated by neutron irradiation, cisplatin and doxorubicin [J]. Cancer Gene Ther, 2005, 12(7):655-662.
  • 9Wu C, Li X, Tian M. Effect of pEgr-TNFalpha gene radiotherapy on mice melanoma [J]. Melanoma Res, 2005, 15(3): 185-190.
  • 10Jiang W, Liao Y, Zhao S. Role of enhanced radiosensitivity and the tumor- specific suicide gene vector in gene therapy of nasopharyngeal carcinoma[J]. J Radiat Res (Tokyo), 2007, 48(3):211-218.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部